2022 annual financial data
Vivos Therapeutics 2022 Net margin
Direct answer
Net margin was -148.81%.
Operating income was -25,031,000 USD and net income was -23,845,000 USD.
Operating cash flow was -19,587,000 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,024,000 USD
- Operating income
- -25,031,000 USD
- Net income
- -23,845,000 USD
- Operating cash flow
- -19,587,000 USD